Release Date: 03/08/20 08:09 Summary: Quarterly Activities Report and Appendix 4C Price Sensitive: Yes Download Document 969.4KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%